ADMA BIOLOGICS INC (ADMA) Stock Cash Flow
NASDAQ:ADMA - Nasdaq - US0008991046 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 206.77M | 197.67M | -28.24M | -65.90M | -71.65M | |||
| Depreciation Amortization | 7.90M | 8.04M | 8.33M | 7.11M | 5.50M | |||
| Income Taxes - Deferred | N/A | -84.28M | N/A | N/A | N/A | |||
| Change In Working Capital | -50.77M | -18.54M | -10.12M | -18.29M | -51.68M | |||
| Interest Paid | 12.83M | 10.67M | 18.05M | 13.88M | 11.16M | |||
| Taxes Paid | N/A | 9.39M | N/A | N/A | N/A | |||
| Other non cash items | 18.17M | 15.77M | 38.83M | 17.57M | 5.46M | |||
| OPERATING CASH FLOW | 101.22M | 118.67M | 8.80M | -59.51M | -112.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.93M | -8.57M | -4.98M | -13.91M | -13.51M | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -10.93M | -8.57M | -4.98M | -13.91M | -13.51M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -60.00M | -23.60M | 51.71M | -30.00K | |||
| Stock Issued/Repurchased | 6.57M | 7.49M | 1.10M | 64.82M | 121.14M | |||
| Other Financing Activity | -10.55M | -5.80M | -16.49M | -7.68M | -60.00K | |||
| FINANCING CASH FLOW | -63.98M | -58.30M | -38.99M | 108.85M | 121.05M | |||
| CHANGE IN CASH | 26.30M | 51.80M | -35.17M | 35.43M | -4.83M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 101.22M | 118.67M | 8.80M | -59.51M | -112.37M | |||
| Capital Expenditure | -10.93M | -8.57M | -4.98M | -13.91M | -13.51M | |||
| FREE CASH FLOW | 90.28M | 110.10M | 3.82M | -73.42M | -125.88M | |||
All data in USD